Akebia Therapeutics (AKBA) Operating Leases (2019 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Operating Leases of $4.9 million for Q3 2025, little changed year-over-year from $4.9 million in Q3 2024, and up 635.62% quarter-over-quarter from $671000.0 in Q2 2025.
Akebia Therapeutics (AKBA) Operating Leases (2019 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Operating Leases for 7 consecutive years, with $4.9 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Operating Leases changed 0.02% year-over-year to $4.9 million; the TTM figure through Sep 2025 stood at $4.9 million (changed 0.02% YoY), while the FY2024 annual figure was $3.5 million, down 60.36% from the prior year.
- Operating Leases grew to $4.9 million in Q3 2025 per AKBA's latest filing, from $671000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $37.7 million in Q1 2022 and bottomed at $671000.0 in Q2 2025.
- Historically, Operating Leases has averaged $18.3 million across 5 years, with a median of $16.2 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Leases soared 67.92% — and 2025, when it tumbled 94.15%.
- Akebia Therapeutics' Operating Leases stood at $33.7 million in 2021, then declined by 14.07% to $29.0 million in 2022, then plunged by 69.11% to $8.9 million in 2023, then tumbled by 60.36% to $3.5 million in 2024, then soared by 39.16% to $4.9 million in 2025.
- Business Quant data shows AKBA's Operating Leases at $4.9 million in Q3 2025, $671000.0 in Q2 2025, and $2.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 671,000.00 |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 16.24 Mn |
| Mar 31, 2023 | 27.42 Mn |
| Dec 31, 2022 | 28.96 Mn |
| Sep 30, 2022 | 35.29 Mn |
| Jun 30, 2022 | 36.50 Mn |
| Mar 31, 2022 | 37.68 Mn |
| Dec 31, 2021 | 33.70 Mn |
| Sep 30, 2021 | 26.33 Mn |
| Jun 30, 2021 | 21.74 Mn |
| Mar 31, 2021 | 28.65 Mn |